ARMO BioSciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch ARMO and buy or sell other stocks, ETFs, and their options commission-free!About ARMO
ARMO BioSciences, Inc. develops immunotherapy for the treatment of cancer, cardiovascular diseases, fibrosis, and inflammation. Its lead product candidate is AM0010 (pegilodecaki).
CEOPhilip L. Johnson
CEOPhilip L. Johnson
Employees—
Employees—
HeadquartersIndianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded2010
Founded2010
Employees—
Employees—
ARMO Key Statistics
Market cap1.52B
Market cap1.52B
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume244.60K
Average volume244.60K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$57.19
52 Week high$57.19
52 Week low$25.10
52 Week low$25.10
Stock Snapshot
The current ARMO BioSciences(ARMO) stock price is $49.98, with a market capitalization of 1.52B.
On 2025-12-08, ARMO BioSciences(ARMO) stock opened at —, reached a high of —, and a low of —.
The ARMO BioSciences(ARMO)'s current trading volume is 0, compared to an average daily volume of 244.6K.
During the past year, ARMO BioSciences(ARMO) stock moved between $25.10 at its lowest and $57.19 at its peak.
During the past year, ARMO BioSciences(ARMO) stock moved between $25.10 at its lowest and $57.19 at its peak.